Quarterly report pursuant to Section 13 or 15(d)

FINANCIAL INSTRUMENTS AND SIGNIFICANT CONCENTRATIONS - Additional Information (Details)

v3.23.1
FINANCIAL INSTRUMENTS AND SIGNIFICANT CONCENTRATIONS - Additional Information (Details) - USD ($)
$ in Thousands
 9 Months Ended
Mar. 31, 2023
Jun. 30, 2022
Mar. 31, 2022
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Concentration Risk, Credit Risk, Uninsured Deposits Financial instruments that subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and investments in marketable debt securities. The Company maintains its cash in demand accounts at a high-quality financial institution. As of and for the nine months ended March 31, 2023 and 2022, cash deposits have exceeded the amount of insurance provided on such deposits by the Federal Deposit Insurance Corporation.    
Cash and cash equivalents, end of period $ 33,743 $ 150,410 $ 63,416
Banking and Financial Services Industries      
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Marketable debt securities 53,100    
U.S. government      
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Marketable debt securities 24,400    
Money Market Mutual Fund      
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Cash and cash equivalents, end of period 20,500    
Checking and Savings Accounts      
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Cash and cash equivalents, end of period $ 13,200 $ 150,400